Literature DB >> 8305680

The leukocyte common antigen, CD45 and other protein tyrosine phosphatases in hematopoietic cells.

T Woodford-Thomas1, M L Thomas.   

Abstract

Numerous protein tyrosine phosphatases have been characterized that are expressed by hematopoietic-derived cells. CD45, a transmembrane protein tyrosine phosphatase expressed by all nucleated cells of hematopoietic origin, has been a prototype for studying the function of these enzymes. In T lymphocytes, CD45 serves to dephosphorylate and activate members of the Src-tyrosine kinase family. Without CD45 function, T cells cannot respond to antigen. Therefore, CD45 functions positively to regulate lymphocyte activation. The characteristics of other protein tyrosine phosphatases found in hematopoietic-derived cells suggests that they are also essential in regulating cell differentiation and activation.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8305680     DOI: 10.1006/scel.1993.1049

Source DB:  PubMed          Journal:  Semin Cell Biol        ISSN: 1043-4682


  11 in total

1.  CD41+ cmyb+ precursors colonize the zebrafish pronephros by a novel migration route to initiate adult hematopoiesis.

Authors:  Julien Y Bertrand; Albert D Kim; Shutian Teng; David Traver
Journal:  Development       Date:  2008-04-16       Impact factor: 6.868

2.  Biological characterization of the UW402, UW473, ONS-76 and DAOY pediatric medulloblastoma cell lines.

Authors:  Ricardo Bonfim-Silva; Karina Bezerra Salomão; Thais Valéria Costa de Andrade Pimentel; Camila Cristina Branquinho de Oliveira Menezes; Patrícia Vianna Bonini Palma; Aparecida Maria Fontes
Journal:  Cytotechnology       Date:  2019-07-26       Impact factor: 2.058

3.  MHC class I and class II molecules are expressed in both human and mouse prostate tumor microenvironment.

Authors:  Navreet K Nanda; Lynn Birch; Norman M Greenberg; Gail S Prins
Journal:  Prostate       Date:  2006-09-01       Impact factor: 4.104

4.  The Use of Patient-Specific Induced Pluripotent Stem Cells (iPSCs) to Identify Osteoclast Defects in Rare Genetic Bone Disorders.

Authors:  I-Ping Chen
Journal:  J Clin Med       Date:  2014-12-17       Impact factor: 4.241

5.  Inhibition of neuronal FLT3 receptor tyrosine kinase alleviates peripheral neuropathic pain in mice.

Authors:  Cyril Rivat; Chamroeun Sar; Ilana Mechaly; Jean-Philippe Leyris; Lucie Diouloufet; Corinne Sonrier; Yann Philipson; Olivier Lucas; Sylvie Mallié; Antoine Jouvenel; Adrien Tassou; Henri Haton; Stéphanie Venteo; Jean-Philippe Pin; Eric Trinquet; Fabienne Charrier-Savournin; Alexandre Mezghrani; Willy Joly; Julie Mion; Martine Schmitt; Alexandre Pattyn; Frédéric Marmigère; Pierre Sokoloff; Patrick Carroll; Didier Rognan; Jean Valmier
Journal:  Nat Commun       Date:  2018-03-12       Impact factor: 14.919

6.  Differential Regulation of CD45 Expression on Granulocytes, Lymphocytes, and Monocytes in COVID-19.

Authors:  Muhammad G T Ahmed; Andreas Limmer; Christoph Sucker; Khaled Mohamed Fares; Sahar Abdel-Baky Mohamed; Ahmed H Othman; Marc Moritz Berger; Thorsten Brenner; Matthias Hartmann
Journal:  J Clin Med       Date:  2022-07-20       Impact factor: 4.964

7.  Dysregulation of the transcription factors SOX4, CBFB and SMARCC1 correlates with outcome of colorectal cancer.

Authors:  C L Andersen; L L Christensen; K Thorsen; T Schepeler; F B Sørensen; H W Verspaget; R Simon; M Kruhøffer; L A Aaltonen; S Laurberg; T F Ørntoft
Journal:  Br J Cancer       Date:  2009-01-20       Impact factor: 7.640

8.  Immunohistochemical Analysis of Scarring Trachoma Indicates Infiltration by Natural Killer and Undefined CD45 Negative Cells.

Authors:  Victor H Hu; Philip J Luthert; Tamsyn Derrick; James Pullin; Helen A Weiss; Patrick Massae; Tara Mtuy; William Makupa; David Essex; David C W Mabey; Robin L Bailey; Martin J Holland; Matthew J Burton
Journal:  PLoS Negl Trop Dis       Date:  2016-05-24

9.  A Depleting Anti-CD45 Monoclonal Antibody as Isolated Conditioning for Bone Marrow Transplantation in the Rat.

Authors:  Mark D Jäger; Florian W R Vondran; Wolf Ramackers; Tilmann Röseler; Hans J Schlitt; Hüseyin Bektas; Jürgen Klempnauer; Kai Timrott
Journal:  PLoS One       Date:  2016-05-03       Impact factor: 3.240

Review 10.  Valid Presumption of Shiga Toxin-Mediated Damage of Developing Erythrocytes in EHEC-Associated Hemolytic Uremic Syndrome.

Authors:  Johanna Detzner; Gottfried Pohlentz; Johannes Müthing
Journal:  Toxins (Basel)       Date:  2020-06-04       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.